Skip to Content

CV Sciences Inc CVSI

Morningstar Rating
$0.03 0.00 (3.08%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CVSI is trading within a range we consider fairly valued.
Price
$0.03
Fair Value
$6.18
Uncertainty
Extreme
1-Star Price
$8.36
5-Star Price
$1.23
Economic Moat
Pfwfh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CVSI is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.03
Day Range
$0.030.03
52-Week Range
$0.030.06
Bid/Ask
$0.03 / $0.03
Market Cap
$5.18 Mil
Volume/Avg
31,577 / 315,375

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.32
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

CV Sciences Inc is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). The company also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based novel therapeutics.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
44

Valuation

Metric
CVSI
Price/Earnings (Normalized)
Price/Book Value
1.49
Price/Sales
0.32
Price/Cash Flow
Price/Earnings
CVSI

Financial Strength

Metric
CVSI
Quick Ratio
0.38
Current Ratio
1.39
Interest Coverage
Quick Ratio
CVSI

Profitability

Metric
CVSI
Return on Assets (Normalized)
−21.87%
Return on Equity (Normalized)
−99.05%
Return on Invested Capital (Normalized)
−73.43%
Return on Assets
CVSI

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AGdhgk$82.1 Bil
MKKGY
Merck KGaA ADRDqtdcd$76.2 Bil
HLN
Haleon PLC ADRKjwy$38.9 Bil
RDY
Dr Reddy's Laboratories Ltd ADRPsc$11.3 Bil
VTRS
Viatris IncLxvw$11.2 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRMhbt$11.1 Bil
CTLT
Catalent IncBffhmk$7.1 Bil
PRGO
Perrigo Co PLCBhh$4.2 Bil
ALKS
Alkermes PLCKyrsz$4.0 Bil
PBH
Prestige Consumer Healthcare IncHszlk$2.9 Bil